Luye Pharma Group Ltd. · LSX:A116Z9
Luye Pharma Group Ltd. shareholders
Luye Pharma Group Ltd. on 6ix: holders from Hong Kong's register and US fund reports. Largest: Luye Pharma Holdings Ltd., LuYe Pharmaceutical Investment Co., Ltd. and Shorea LBG. Each with its filing.
| Holder | Shares | % of Luye Pharma Group Ltd. | Change | As of |
|---|---|---|---|---|
| Luye Pharma Holdings Ltd. | 1.25B | 31.2% | Sep 29, 2026 | |
| LuYe Pharmaceutical Investment Co., Ltd. | 1.25B | 31.2% | Sep 29, 2026 | |
| Shorea LBG | 1.25B | 31.2% | Sep 29, 2026 | |
| Ginkgo (PTC) Limited | 1.25B | 31.2% | Sep 29, 2026 | |
| Luye Life Sciences Group Ltd | 1.25B | 31.2% | Sep 29, 2026 | |
| Liu Dianbo | 1.25B | 31.2% | Sep 29, 2026 | |
| LuYe Pharmaceutical International Co., Ltd. | 1.25B | 31.2% | Sep 29, 2026 | |
| Nelumbo Investments Limited | 1.25B | 31.2% | Sep 29, 2026 | |
| UBS Group AG | 561M | 14.0% | Oct 13, 2026 | |
| Hillhouse Investment Management, Ltd. | 552M | 13.8% | Sep 10, 2025 |